Mashlo 4mg FlexTouch is used for:

• Type 2 diabetes mellitus: To improve blood sugar control in adults along with diet and exercise.

• Chronic weight management: Semaglutide may be prescribed as part of a reduced-calorie diet and increased physical activity for appropriate adults.

Mashlo contains Semaglutide, which activates GLP-1 receptors involved in blood sugar regulation and appetite control.

It increases insulin release when blood sugar is high, reduces glucagon release and slows stomach emptying. These actions help improve blood sugar control and may reduce food intake.

Tell your doctor about all medicines, supplements and herbal products you take.

• Insulin or sulfonylureas: May increase the risk of low blood sugar.

• Oral medicines: Delayed stomach emptying may affect the absorption of some oral medicines.

• Other GLP-1 receptor agonists: Do not use Mashlo with another Semaglutide-containing medicine or GLP-1 receptor agonist unless prescribed.

• Medicines requiring monitoring: Tell your doctor about medicines that need regular monitoring.

• Store Mashlo 4mg FlexTouch in a refrigerator at 2°C to 8°C.

• Do not freeze.

• Do not use if frozen.

• Protect from light.

• Keep out of reach of children.

• Follow the pack instructions after first use.

Use Mashlo 4mg FlexTouch exactly as prescribed.

The 4mg/3mL pen is used to deliver 1mg doses of Semaglutide. It is injected under the skin once weekly into the abdomen, thigh or upper arm.

The dose is generally increased gradually after treatment initiation. Your doctor will decide the dose according to your treatment response and tolerance.

Common side effects include 

• Nausea 

• vomiting 

• diarrhoea 

• constipation

• abdominal pain 

• decreased appetite 

• headache 

• dizziness.

Serious side effects:

• Severe or persistent abdominal pain

• Severe allergic reactions

• Persistent vomiting or diarrhoea with dehydration

• Gallstones or gallbladder inflammation

• Sudden or worsening changes in vision

• Low blood sugar when used with insulin or sulfonylureas

Seek medical attention if severe or persistent symptoms occur.

• Remember that 4mg refers to the total Semaglutide content in the pen.

• The 4mg/3mL presentation is used to deliver 1mg doses.

• Use Mashlo on the same day each week.

• Rotate injection sites.

• Monitor blood sugar as advised if using Mashlo for diabetes.

• Drink enough fluids if you experience vomiting or diarrhoea.

• Tell your doctor before surgery or deep sedation.

• Do not share the pen or needles.